Kratom, a plant-derived substance with opioid-like effects, faces renewed scrutiny as Robert F. Kennedy Jr. seeks to ban a key ingredient known as 7-OH. MAHA’s decision to back one side in this intensifying debate underscores the conflict’s potential to shape future health policy.

In a late-night summary, the Associated Press highlights the contentious nature of RFK Jr.’s appearance before Senate lawmakers. Though details are limited, the article offers an overview of the key issues shaping the hearing and the broader political debate.